Document Mentions (4 shared documents)

EFTA00136746

2 mentions1 same-page

Page ?Same page

ing on `unsustainable drug prices' concludes — Hybrid hearing on `Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM * Tom Lantos Human

• Birx Seeks To Reassure Americans Of Vaccine Safety. • Modema Says Its Vaccine Won't Be Ready Until Spring 2021. • FDA Broadens Investigation Of AstraZeneca's Coronavirus Vaccine Trial. • White House Rejected CDC's Request For Cruise Ship Ban Extension. • CDC Report On Meatpacking Plant Safety Procedure

EFTA00135712

2 mentions1 same-page

Page ?Same page

ing on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

• Birx Seeks To Reassure Americans Of Vaccine Safety. • Moderna Says Its Vaccine Won't Be Ready Until Spring 2021. • FDA Broadens Investigation Of AstraZeneca's Coronavirus Vaccine Trial. • White House Rejected CDC's Request For Cruise Ship Ban Extension. • CDC Report On Meatpacking Plant Safety Procedure

EFTA00148896

2 mentions1 same-page

Page ?Same page

ring on `unsustainable drug prices' concludes - Hybrid hearing on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human